AB155078

重组Anti-CKS2抗体[EPR7946(2)]

Name: CKS2抗体[EPR7946(2)] (ab155078)| Abcam中文官网
Brand: Abcam Limited
SKU: AB155078
Price: 2534 CNY
Availability: InStock
Rating: 4 (1 reviews)

Anti-CKS2 antibody [EPR7946(2)]

RabMAb
Recombinant
了解详情

(1 Review)

(17 Publications)

Rabbit Recombinant Monoclonal CKS2 antibody. Suitable for WB and reacts with Human samples. Cited in 17 publications.

查看别名

Cyclin-dependent kinases regulatory subunit 2, CKS-2, CKS2

1 Images

Unknown

Western blot - Anti-CKS2 antibody [EPR7946(2)] (AB155078)

All lanes:

Western blot - Anti-CKS2 antibody [EPR7946(2)] (ab155078) at 1/1000 dilution

Lane 1:

Caco-2 cell lysate at 10 µg

Lane 2:

293T cell lysate at 10 µg

Lane 3:

MOLT4 cell lysate at 10 µg

Predicted band size: 10 kDa

false

不同偶联物与剂型 (8)

Carrier free

Anti-CKS2 antibody [EPR7946(2)] - BSA and Azide free
519 Alexa Fluor® 488

Alexa Fluor® 488 Anti-CKS2 antibody [EPR7946(2)]
578 PE

PE Anti-CKS2 antibody [EPR7946(2)]
660 APC

APC Anti-CKS2 antibody [EPR7946(2)]
665 Alexa Fluor® 647

Alexa Fluor® 647 Anti-CKS2 antibody [EPR7946(2)]
617 Alexa Fluor® 594

Alexa Fluor® 594 Anti-CKS2 antibody [EPR7946(2)]
565 Alexa Fluor® 555

Alexa Fluor® 555 Anti-CKS2 antibody [EPR7946(2)]
775 Alexa Fluor® 750

Alexa Fluor® 750 Anti-CKS2 antibody [EPR7946(2)]

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR7946(2)

亚型

IgG

不含载体蛋白

反应种属

Human

应用

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

style

left-column

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Mouse": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Drosophila melanogaster": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

style

left-column

产品详情

Patented technology
Our RabMAb^® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb^® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production

For more information, read more on recombinant antibodies.

style

left-column

性能和储存信息

形式

Liquid

纯化工艺

Affinity purification Protein A

存储溶液

pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 0.05% BSA

运输条件

Blue Ice

分装信息

Upon delivery aliquot

储存信息

Avoid freeze / thaw cycle

style

left-column

style

left-column

style

left-column

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

Visit the General protocols
Visit the Troubleshooting

style

left-column

靶点信息

Binds to the catalytic subunit of the cyclin dependent kinases and is essential for their biological function.

See full target information CKS2

style

left-column

文献 (17)

Recent publications for all applications. Explore the full list and refine your search

Translational cancer research 14:5045-5058 PubMed40950663

2025

Facilitation of natural killer T-cell cytotoxic activity in uterine sarcoma via the axis.

Applications

Unspecified application

Species

Unspecified reactive species

Yali Du,Ting Lan,Mengyuan Liu,Weiyan Wu,Jinqi Ma

BMC cancer 25:1182 PubMed40676553

2025

DNMT1 blocks SOX21-repressed CKS2 transcription to promote gastric cancer progression.

Applications

Unspecified application

Species

Unspecified reactive species

Jie Wei,Song Xue,Xinglong Du,Yuanfei Dai,Yuting Ji,Guangsi He

Cancer medicine 13:e70435 PubMed39560180

2024

Unveiling CKS2: A Key Player in Aggressive B-Cell Lymphoma Progression and a Target for Synergistic Therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Fenling Zhou,Lu Chen,Zhen Liu,Yuli Cao,Cuilan Deng,Gexiu Liu,Chengcheng Liu

Translational oncology 47:102042 PubMed38924847

2024

Integrated analysis of histone modification features in clear cell renal cancer for risk stratification and therapeutic prediction.

Applications

Unspecified application

Species

Unspecified reactive species

Wenming Ma,Qintao Ge,Yu Guan,Li Zhang,Liqun Huang,Lei Chen,Wenlong Xu,Jialin Meng,Guosheng Yang,Chaozhao Liang

Vascular medicine (London, England) 29:369-380 PubMed38623630

2024

Alleviating iatrogenic effects of paclitaxel via antiinflammatory treatment.

Applications

Unspecified application

Species

Unspecified reactive species

Mengwei Zhang,Saran Lotfollahzadeh,Nagla Elzinad,Xiaosheng Yang,Murad Elsadawi,Adam C Gower,Mostafa Belghasem,Tarek Shazly,Vijaya B Kolachalama,Vipul C Chitalia

Journal of hepatocellular carcinoma 10:1767-1784 PubMed37841370

2023

Expression of CKS2 in Hepatocellular Carcinoma: Correlation with Survival Outcomes and Immune Microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Renhou Zhi,Pengfei Hao,Weibin Li,Haoliang Zhao

Translational cancer research 12:2276-2293 PubMed37859732

2023

Identification of as a novel prognostic biomarker and potential therapeutic target for oral squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Danqi Qiu,Hongshi Cai,Jianfeng Liang,Ziyi Wang,Fan Song,Yaoqi Jiang,Rukeng Tan,Jingsong Hou

Cell death & disease 13:784 PubMed36096885

2022

E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Meng Chen,Zhaozhao Zhao,Lianqun Wu,Jiancheng Huang,Peng Yu,Jiang Qian,Ting Ni,Chen Zhao

Drug development research 83:1589-1599 PubMed35903032

2022

Knockdown of replication protein A 3 induces protective autophagy and enhances cisplatin sensitivity in lung adenocarcinoma by inhibiting AKT/mTOR signaling via binding to cyclin-dependent kinases regulatory subunit 2.

Applications

Unspecified application

Species

Unspecified reactive species

Lijun Chen,Ke Hu,Yu Liu,Lingli Liu,Juanjuan Tang,Xiaobing Qin

International journal of oncology 60: PubMed35059737

2022

Overexpression of Parkin in clear cell renal cell carcinoma decreases tumor aggressiveness by regulating CKS2 levels.

Applications

Unspecified application

Species

Unspecified reactive species

Laura Kristin Esser,Vittorio Branchi,Farhad Shakeri,Adrian Georg Simon,Carsten Stephan,Glen Kristiansen,Andreas Buness,Hubert Schorle,Marieta Ioana Toma

View all publications

style

left-column

style

left-column

style

right-column

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂，为您科研的每一步提供支持。若我们的产品未能达到预期性能，我们向您提供 Abcam Product Promise 保障。

详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com

重组Anti-CKS2抗体[EPR7946(2)]